<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02692495</url>
  </required_header>
  <id_info>
    <org_study_id>200904010001MEBO</org_study_id>
    <nct_id>NCT02692495</nct_id>
  </id_info>
  <brief_title>Evaluation of Potential Screening Tools for Metabolic Body Odor and Halitosis</brief_title>
  <official_title>Evaluation of Gastrointestinal and Nutritional Diagnostic Tests as Potential Screening Tools for Metabolic Body Odor and Halitosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mebo Research, Inc.</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mebo Research, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed as a retrospective cohort study to evaluate the potential of
      diagnostic procedures in defining populations of patients self-reporting unexpected and
      uncontrollable episodes of body odor and/or halitosis. The cohort - generally healthy
      individuals who had underwent multiple diagnostic tests recommended by their physicians and
      had not been diagnosed with any known medical condition - expressed their interest in trying
      gastrointestinal and nutritional diagnostic tests offered by Biolab Medical Unit. Our
      retrospective analysis will determine if these tests were useful as potential screening tools
      for metabolic body odor and halitosis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Many yet uncharacterized medical conditions including inborn and acquired errors of
      metabolism or skewed microbiome could be responsible for unpredictable and uncontrollable
      episodes of body odor and halitosis. These conditions have dramatic impact on the quality of
      life and socioeconomic outcomes of sufferers. Yet clinics and specialized malodor centers do
      not provide tests for diagnosing malodor other than trimethylaminuria (TMAU). Self-reported
      odor problems are often dismissed if are not organoleptically evaluated by trained odor
      judges that are not readily available during malodor flare-ups.

      The aim of this study is to analyze effectiveness of existing gastrointestinal and
      nutritional tests for the assessment and investigation of self-reported malodors.

      Diagnostic tests included:

        -  Gut Permeability Profile. PEG 400 is used as a probe and measured in urine passed for
           the following 6 hours at 11 different molecular weights to establish the quantity of
           each absorbed through the gut wall. Extraction and separation of PEG from urine is done
           by ion exchange chromatography and capillary GLC.

        -  Gut Fermentation Profile. Blood alcohols - ethanol, methanol, butanol, propanol and
           short chain fatty acids - are measured by gas-liquid chromatography.

        -  D-lactate test. D-lactate is measured by centrifugal analysis using the specific enzyme
           D-lactate dehydrogenase, which does not react with L-lactate

        -  The urine indicans (Obermeyer) test. Detection of indican in the urine depends upon its
           decomposition and subsequent oxidation of indoxyl to indigo blue and its absorption into
           a chloroform layer

        -  Breath test for small intestinal dysbiosis. Breath hydrogen and methane are measured by
           gas-liquid chromatography. The patient is given 10 gm of lactulose in 200 ml of water
           and alveolar air samples are collected every 20 minutes for 3 hours

        -  Functional B vitamins profile, by measuring the activation of a red cell enzyme that is
           dependent upon an adequate concentration of a particular vitamin for full activity. The
           assay relies on normal metabolism of the vitamin to its native form and the presence of
           other non-vitamin cofactors.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">February 2016</completion_date>
  <primary_completion_date type="Actual">December 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Test Results Outside the Normal Range</measure>
    <time_frame>four years</time_frame>
    <description>The investigators would like to evaluate the strength of evidence in diagnostic accuracy of laboratory tests taken by participants (listed in the detailed description of the study), for diagnosing malodor syndromes. Values measured by the laboratory (Biolab Medical Unit) will be compared against the reference range specific to that laboratory.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Discriminative Biomarkers in the Subgroups of Malodor</measure>
    <time_frame>three years</time_frame>
    <description>The investigators have comprehensively analyzed diagnostic ability of tests taken by participants to correlate with their symptoms using several statistical techniques known to bring out strong patterns in a dataset. Principal component analysis (PCA) allowed to clearly separate data into two clusters (&quot;Sour&quot; and &quot;Sweet&quot;) shown below along with the &quot;Lactic&quot; subgroup from the &quot;Sour&quot; group.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Test Results Outside the Normal Range in Different Subgroups of Malodor</measure>
    <time_frame>Three years</time_frame>
    <description>Disciminative biomarkers for groups of malodor discovered using PCA, compared to control group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average Daily Added Sugar Intake Inferred From Self-reported Dietary Data in the Subgroups of Malodor</measure>
    <time_frame>Three years</time_frame>
    <description>The measurement of dietary intake of selected nutrients from self-reported food intakes and diet history questionnaires. Correlation of symptoms with added sugar in the diet were noted independently on the source of malodor.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">16</enrollment>
  <condition>Nutritional and Metabolic Diseases</condition>
  <arm_group>
    <arm_group_label>Body odor</arm_group_label>
    <description>individuals self-reporting recurrent episodes of uncontrollable body odor with or without halitosis</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Halitosis</arm_group_label>
    <description>individuals with extra-oral halitosis, not complaining of body odors</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals reporting idiopathic malodor production
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  idiopathic malodor experienced over a period of several months or years

          -  willing and able to complete the study

          -  good general health

        Exclusion Criteria:

          -  elect not to participate in the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Irene Gabashvili, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MeBO Research</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>MeBO Research LTD</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>W10 5LE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <reference>
    <citation>Chadwick VS, Phillips SF, Hofmann AF. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). I. Chemical analysis and biological properties of PEG 400. Gastroenterology. 1977 Aug;73(2):241-6.</citation>
    <PMID>873124</PMID>
  </reference>
  <reference>
    <citation>Sivakumaran T, Jenkins RT, Walker WH, Goodacre RL. Simplified measurement of polyethylene glycol 400 in urine. Clin Chem. 1982 Dec;28(12):2452-3.</citation>
    <PMID>7139937</PMID>
  </reference>
  <reference>
    <citation>Hunnisett A., Howard J., Davies S. Gut fermentation (or the 'Auto-brewery') Syndrome: A new clinical test with initial observations and discussion of clinical and biochemical implications J.Nutr.Med.1:33-8, 1990</citation>
  </reference>
  <reference>
    <citation>Sheedy JR, Wettenhall RE, Scanlon D, Gooley PR, Lewis DP, McGregor N, Stapleton DI, Butt HL, DE Meirleir KL. Increased d-lactic Acid intestinal bacteria in patients with chronic fatigue syndrome. In Vivo. 2009 Jul-Aug;23(4):621-8.</citation>
    <PMID>19567398</PMID>
  </reference>
  <reference>
    <citation>Ludvigsen CW, Thurn JR, Pierpont GL, Eckfeldt JH. Kinetic enzymic assay for D(-)-lactate, with use of a centrifugal analyzer. Clin Chem. 1983 Oct;29(10):1823-5.</citation>
    <PMID>6616831</PMID>
  </reference>
  <reference>
    <citation>Jenq RR. How's your microbiota? Let's check your urine. Blood. 2015 Oct 1;126(14):1641-2. doi: 10.1182/blood-2015-08-661504.</citation>
    <PMID>26429966</PMID>
  </reference>
  <reference>
    <citation>Khoshini R, Dai SC, Lezcano S, Pimentel M. A systematic review of diagnostic tests for small intestinal bacterial overgrowth. Dig Dis Sci. 2008 Jun;53(6):1443-54. Review.</citation>
    <PMID>17990113</PMID>
  </reference>
  <reference>
    <citation>Drossman DA. The functional gastrointestinal disorders and the Rome III process. Gastroenterology. 2006 Apr;130(5):1377-90. Review.</citation>
    <PMID>16678553</PMID>
  </reference>
  <reference>
    <citation>Mount JN, Heduan E, Herd C, Jupp R, Kearney E, Marsh A. Adaptation of coenzyme stimulation assays for the nutritional assessment of vitamins B1, B2 and B6 using the Cobas Bio centrifugal analyser. Ann Clin Biochem. 1987 Jan;24 ( Pt 1):41-6.</citation>
    <PMID>3827183</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2016</study_first_submitted>
  <study_first_submitted_qc>February 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 26, 2016</study_first_posted>
  <results_first_submitted>March 8, 2016</results_first_submitted>
  <results_first_submitted_qc>June 3, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">January 24, 2018</results_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>body odor</keyword>
  <keyword>halitosis</keyword>
  <keyword>dysbiosis</keyword>
  <keyword>leaky gut</keyword>
  <keyword>microbiome</keyword>
  <keyword>PATM</keyword>
  <keyword>breath odor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Halitosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>de-identified individual participant data will be made partially available</ipd_description>
  </patient_data>
  <study_docs>
    <study_doc>
      <doc_id>10.17632/8bk6h6bmkr.1</doc_id>
      <doc_type>Individual Participant Data Set</doc_type>
      <doc_url>https://data.mendeley.com/datasets/8bk6h6bmkr/1</doc_url>
    </study_doc>
    <study_doc>
      <doc_type>Clinical Study Report</doc_type>
      <doc_url>http://www.aurametrix.com/nct02692495</doc_url>
    </study_doc>
    <study_doc>
      <doc_id>10.1101/139014</doc_id>
      <doc_type>Preprint</doc_type>
      <doc_url>http://biorxiv.org/content/early/2017/05/19/139014</doc_url>
      <doc_comment>Study results</doc_comment>
    </study_doc>
  </study_docs>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Body Odor</title>
          <description>individuals self-reporting recurrent episodes of uncontrollable body odor with or without halitosis</description>
        </group>
        <group group_id="P2">
          <title>Halitosis</title>
          <description>individuals with halitosis (bad breath), not complaining of body odors</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Body Odor</title>
          <description>individuals self-reporting recurrent episodes of uncontrollable body odor with or without halitosis</description>
        </group>
        <group group_id="B2">
          <title>Halitosis</title>
          <description>individuals with halitosis, not complaining of body odors</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
            <count group_id="B2" value="4"/>
            <count group_id="B3" value="16"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="30.9" spread="8.5"/>
                    <measurement group_id="B2" value="37.5" spread="5.9"/>
                    <measurement group_id="B3" value="32.6" spread="8.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United Kingdom</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration of condition</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Age at onset of symptoms</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21" spread="9"/>
                    <measurement group_id="B2" value="29" spread="9"/>
                    <measurement group_id="B3" value="23" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Duration of symptoms</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="9" spread="6"/>
                    <measurement group_id="B2" value="9" spread="5"/>
                    <measurement group_id="B3" value="9" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Test Results Outside the Normal Range</title>
        <description>The investigators would like to evaluate the strength of evidence in diagnostic accuracy of laboratory tests taken by participants (listed in the detailed description of the study), for diagnosing malodor syndromes. Values measured by the laboratory (Biolab Medical Unit) will be compared against the reference range specific to that laboratory.</description>
        <time_frame>four years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Body Odor</title>
            <description>individuals self-reporting recurrent episodes of uncontrollable body odor with or without halitosis</description>
          </group>
          <group group_id="O2">
            <title>Halitosis</title>
            <description>individuals with halitosis, not complaining of body odors</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Test Results Outside the Normal Range</title>
          <description>The investigators would like to evaluate the strength of evidence in diagnostic accuracy of laboratory tests taken by participants (listed in the detailed description of the study), for diagnosing malodor syndromes. Values measured by the laboratory (Biolab Medical Unit) will be compared against the reference range specific to that laboratory.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Elevated blood ethanol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elevated blood methanol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elevated 1-propanol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elevated 2-propanol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elevated 2-methyl-1-propanol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elevated 2-methyl-2-propanol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elevated 1-butanol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elevated 2-butanol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elevated 2-methyl-1-butanol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elevated 2-methyl-2-butanol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elevated 2-ethyl-1-butanol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Elevated 2,3-butylene glycol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Increased blood acetate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Decreased blood acetate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Decreased blood propionate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Decreased blood butyrate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood Succinate out of range</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Blood Valerate out of range</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Increased gut permeability</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Decreased gut permeability</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>increased blood D-lactate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>increased urine Indicans</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Discriminative Biomarkers in the Subgroups of Malodor</title>
        <description>The investigators have comprehensively analyzed diagnostic ability of tests taken by participants to correlate with their symptoms using several statistical techniques known to bring out strong patterns in a dataset. Principal component analysis (PCA) allowed to clearly separate data into two clusters (&quot;Sour&quot; and &quot;Sweet&quot;) shown below along with the &quot;Lactic&quot; subgroup from the &quot;Sour&quot; group.</description>
        <time_frame>three years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>&quot;Sour&quot; Group</title>
            <description>Self-reported predominant odors included “fishy”, “ammonia”, sour acetone (body odor associated with alcoholism), fecal-diarrheal, and generic “fecal odor”</description>
          </group>
          <group group_id="O2">
            <title>&quot;Sweet&quot; Group</title>
            <description>Self-reported odors mostly identified as gas, benzene, “burning”,“sulfur”, “rotten vegetables”, “rotten eggs”, cheesy/sweaty and sulfury fecal, sewage, “burning”, and elusive odors that could not be smelled by the sufferer including “PATM” condition (odors could not be named, but people near the sufferer exhibited increased displeasure, coughing, sneezing, and rubbing their noses).</description>
          </group>
          <group group_id="O3">
            <title>&quot;Lactic&quot; Subgroup</title>
            <description>&quot;Garbage&quot; odor identified as one of the most common types of odor (subgroup of the &quot;Sour&quot; cluster)</description>
          </group>
        </group_list>
        <measure>
          <title>Discriminative Biomarkers in the Subgroups of Malodor</title>
          <description>The investigators have comprehensively analyzed diagnostic ability of tests taken by participants to correlate with their symptoms using several statistical techniques known to bring out strong patterns in a dataset. Principal component analysis (PCA) allowed to clearly separate data into two clusters (&quot;Sour&quot; and &quot;Sweet&quot;) shown below along with the &quot;Lactic&quot; subgroup from the &quot;Sour&quot; group.</description>
          <units>umol/L</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
                <count group_id="O3" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>D-lactate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" spread="5"/>
                    <measurement group_id="O2" value="29" spread="39"/>
                    <measurement group_id="O3" value="330" spread="245"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2- butanol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.8"/>
                    <measurement group_id="O2" value="0.9" spread="0.7"/>
                    <measurement group_id="O3" value="3.2" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Butyrate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" spread="6"/>
                    <measurement group_id="O2" value="11" spread="3"/>
                    <measurement group_id="O3" value="6" spread="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2,3-butylene glycol</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.6" spread="1.4"/>
                    <measurement group_id="O2" value="1.6" spread="1.5"/>
                    <measurement group_id="O3" value="6.0" spread="0.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Acetate</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="60.6" spread="16.9"/>
                    <measurement group_id="O2" value="68.7" spread="22.5"/>
                    <measurement group_id="O3" value="55.5" spread="37.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.01</p_value>
            <method>t-test, 2 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Test Results Outside the Normal Range in Different Subgroups of Malodor</title>
        <description>Disciminative biomarkers for groups of malodor discovered using PCA, compared to control group</description>
        <time_frame>Three years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>&quot;Sour&quot; Group</title>
            <description>Self-reported predominant odors included “fishy”, “ammonia”, sour acetone (body odor associated with alcoholism), fecal-diarrheal, and generic “fecal odor”</description>
          </group>
          <group group_id="O2">
            <title>&quot;Sweet&quot; Group</title>
            <description>Self-reported odors mostly identified as gas, benzene, “burning”,“sulfur”, “rotten vegetables”, “rotten eggs”, cheesy/sweaty and sulfury fecal, sewage, “burning”, and elusive odors that could not be smelled by the sufferer including “PATM” condition (odors could not be named, but people near the sufferer exhibited increased displeasure, coughing, sneezing, and rubbing their noses).</description>
          </group>
          <group group_id="O3">
            <title>&quot;Lactic&quot; Subgroup</title>
            <description>&quot;Garbage&quot; odor identified as one of the most common types of odor</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Test Results Outside the Normal Range in Different Subgroups of Malodor</title>
          <description>Disciminative biomarkers for groups of malodor discovered using PCA, compared to control group</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
                <count group_id="O3" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Ethanol, blood</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Indicans, urine</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="4"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>B2 vitamin, blood (EGFR activation)</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="5"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>D lactate, plasma</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Average Daily Added Sugar Intake Inferred From Self-reported Dietary Data in the Subgroups of Malodor</title>
        <description>The measurement of dietary intake of selected nutrients from self-reported food intakes and diet history questionnaires. Correlation of symptoms with added sugar in the diet were noted independently on the source of malodor.</description>
        <time_frame>Three years</time_frame>
        <group_list>
          <group group_id="O1">
            <title>&quot;Sour&quot; Group</title>
            <description>Self-reported predominant odors included “fishy”, “ammonia”, sour acetone (body odor associated with alcoholism), fecal-diarrheal, and generic “fecal odor”</description>
          </group>
          <group group_id="O2">
            <title>&quot;Sweet&quot; Group</title>
            <description>Self-reported odors mostly identified as gas, benzene, “burning”,“sulfur”, “rotten vegetables”, “rotten eggs”, cheesy/sweaty and sulfury fecal, sewage, “burning”, and elusive odors that could not be smelled by the sufferer including “PATM” condition (odors could not be named, but people near the sufferer exhibited increased displeasure, coughing, sneezing, and rubbing their noses).</description>
          </group>
          <group group_id="O3">
            <title>&quot;Lactic&quot; Subgroup</title>
            <description>&quot;Garbage&quot; odor identified as one of the most common types of odor</description>
          </group>
        </group_list>
        <measure>
          <title>Average Daily Added Sugar Intake Inferred From Self-reported Dietary Data in the Subgroups of Malodor</title>
          <description>The measurement of dietary intake of selected nutrients from self-reported food intakes and diet history questionnaires. Correlation of symptoms with added sugar in the diet were noted independently on the source of malodor.</description>
          <units>grams per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="7"/>
                <count group_id="O2" value="7"/>
                <count group_id="O3" value="2"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5" spread="5"/>
                    <measurement group_id="O2" value="25" spread="10"/>
                    <measurement group_id="O3" value="20" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>All participants were followed up by email for at least one week after discussing their test results.</time_frame>
      <desc>Adverse effects were defined as any events, expected or not, that affected participant well being, regardless of whether there was a causal relationship with the diagnostic testing and discussion of the results.
Serious adverse events were defined as those that prevented a participant from performing normal activities and required treatment.</desc>
      <group_list>
        <group group_id="E1">
          <title>Body Odor</title>
          <description>individuals self-reporting recurrent episodes of uncontrollable body odor with or without halitosis</description>
        </group>
        <group group_id="E2">
          <title>Halitosis</title>
          <description>individuals self-reporting breath malodors but not body odors</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="4"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Irene Gabashvili, Scientific Director</name_or_title>
      <organization>MEBO Research</organization>
      <phone>(408) 341-9355</phone>
      <email>irene.gabashvili@meboresearch.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

